Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 4, 2005, Pages 424-

  Vilar, Eduardo ^a   Tabernero, Josep ^a   Casado, Esther ^a   Macarulla, Teresa ^a   Ramos, Francisco J ^a   Martinelli, Erika ^a   Saura, Cristina ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; INTERFERON; KI 67 ANTIGEN; PEPTIDE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

ADVANCED CANCER; CANCER SURVIVAL; DRUG EFFICACY; ENDOCRINE TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; METASTASIS; PANCREAS TUMOR; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; HUMANS; PANCREATIC NEOPLASMS; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 23244456249     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000162426.79311.a5     Document Type: Letter

References (6)

1. McCollum AD, Kulke MH, Ryan DP, et al. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors. Am J Clin Oncol. 2004;27:485-488.
2. Moertel CG, Lefkopoulo M, Lipsitz S, et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992;326:519-523.
3. Clarke MR, Baker EE, Weyant RJ, et al. Proliferative activity in pancreatic endocrine tumors: association with function, metastases, and survival. Endocr Pathol. 1997;8:181-187.
4. Gentil Perret A, Mosnier JF, Buono JP, et al. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol. 1998;109:286-293.
5. Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Acta Oncol. 2004;43:626-636.
6. Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Acta Oncol. 2004;43:617-625.